This project aims to develop an innovative physical approach to accurately predict the location of a moving lung tumor during streotactic body radiotherapy (SBRT). The strategy involves using four-dimensional computed tomography (4DCT) to calibrate a tumor base-model at simulation and using video-based optical surface imaging (4DSI) to provide motion adaptation to infer tumor position during treatment. This tumor motion model accounts for breathing irregularities and baseline drift, which cannot be handled by any existing correlation-based motion surrogate. Therefore, the proposed method potentially provides an accurate, reliable, and non-radiological means of monitoring a moving tumor for motion-tracking SBRT. Previously, Dr. Li discovered the physical relationships of torso-volume change with dynamic tidal volume and mean diaphragm motion. He has collaborated with Dr. Wei for 1.5 years and published 2 papers on lung motion characterization and breathing periodicity, facilitated by Dr. Wei's expertise in computer vision and machine learning. Preliminary data have been generated, including accuracy assessment of 4DSI in volume measurement, framework for a tumor motion perturbation model, and characterization of lung ventilation and motion. We therefore hypothesize that this physical law-based method will provide an accurate estimation of tumor location, thereby potentially improving radiation therapy for cancer. In particular, we propose to establish a tumor motion perturbation model using both 4DCT and 4DSI. We will characterize the physical relationship between a moving tumor and the bronchial tree, chest wall, diaphragm, and torso surface (see Specific Aim 1). We will build a motion base model, apply 4DSI for spatial and temporal inputs, and finalize the motion perturbation model. We also propose to establish 4DSI-based spirometry and clinically validate the proposed method, through both volunteer and patient studies (see Specific Aim 2). We will establish an IRB protocol for patient studies using concurrent 4DSI and fluoroscopy to validate the tumor motion model. We will also study volunteer respiration using 4DMR and spirometry. This pilot project will demonstrate the proof of principle that this novel approach can accurately target lung tumors in 4D image-guided SBRT.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-Y)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
Yeh, Yi-Chen; Nitadori, Jun-ichi; Kadota, Kyuichi et al. (2015) Using frozen section to identify histological patterns in stage I lung adenocarcinoma of ? 3 cm: accuracy and interobserver agreement. Histopathology 66:922-38
Mandelblatt, Jeanne S; Jacobsen, Paul B; Ahles, Tim (2014) Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol 32:2617-26
Guidry, John A; Lubetkin, Erica; Corner, Geoffrey et al. (2014) Promoting cancer prevention and control in community-based HIV/AIDS service organizations: are they ready? AIDS Educ Prev 26:43-55
Kadota, Kyuichi; Yeh, Yi-Chen; Sima, Camelia S et al. (2014) The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 27:690-700
Eguchi, Takashi; Kadota, Kyuichi; Park, Bernard J et al. (2014) The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know. Semin Thorac Cardiovasc Surg 26:210-22
Dereli-Korkut, Zeynep; Akaydin, H Dogus; Ahmed, A H Rezwanuddin et al. (2014) Three dimensional microfluidic cell arrays for ex vivo drug screening with mimicked vascular flow. Anal Chem 86:2997-3004
Lee, Ming-Ching; Buitrago, Daniel H; Kadota, Kyuichi et al. (2014) Recent advances and clinical implications of the micropapillary histological subtype in lung adenocarcinomas. Lung Cancer Manag 3:245-253
Kachala, Stefan S; Bograd, Adam J; Villena-Vargas, Jonathan et al. (2014) Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma. Clin Cancer Res 20:1020-8
de Biasi, Andreas R; Villena-Vargas, Jonathan; Adusumilli, Prasad S (2014) Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence. Clin Cancer Res 20:5384-91
Lubetkin, Erica I; Zabor, Emily C; Brennessel, Debra et al. (2014) Beyond demographics: differences in patient activation across new immigrant, diverse language subgroups. J Community Health 39:40-9

Showing the most recent 10 out of 38 publications